P
Philip G. Conaghan
Researcher at National Institute for Health Research
Publications - 31
Citations - 1218
Philip G. Conaghan is an academic researcher from National Institute for Health Research. The author has contributed to research in topics: Osteoarthritis & Rheumatoid arthritis. The author has an hindex of 13, co-authored 31 publications receiving 921 citations. Previous affiliations of Philip G. Conaghan include University of Leeds & Chapel Allerton Hospital.
Papers
More filters
Journal ArticleDOI
Acupuncture for Chronic Knee Pain: A Randomized Clinical Trial
Rana S Hinman,Paul McCrory,Marie Pirotta,Ian Relf,Andrew Forbes,Kay M. Crossley,Elizabeth A. Williamson,Mary Kyriakides,Kitty Novy,Ben R Metcalf,Anthony Harris,Prasuna Reddy,Philip G. Conaghan,Kim L Bennell +13 more
TL;DR: In patients older than 50 years with moderate or severe chronic knee pain, neither laser nor needle acupuncture conferred benefit over sham for pain or function, and the findings do not support acupuncture for these patients.
Journal ArticleDOI
Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib
Marc C. Hochberg,Johanne Martel-Pelletier,Jordi Monfort,Ingrid Möller,Castillo,Nigel K Arden,Nigel K Arden,Nigel K Arden,Francis Berenbaum,Francisco J. Blanco,Philip G. Conaghan,Gema Domenech,Yves Henrotin,Thomas Pap,Pascal Richette,Allen D. Sawitzke,Patrick du Souich,Jean-Pierre Pelletier +17 more
TL;DR: CS+GH has comparable efficacy to celecoxib in reducing pain, stiffness, functional limitation and joint swelling/effusion after 6 months in patients with painful knee osteoarthritis, with a good safety profile.
Journal Article
Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema.
Marissa Lassere,Kent R Johnson,Kent R Johnson,Maarten Boers,Peter Tugwell,Peter Brooks,Lee S. Simon,Vibeke Strand,Philip G. Conaghan,Mikkel Østergaard,Walter P. Maksymowych,Robert Landewé,Barry Bresnihan,Paul P. Tak,Richard J. Wakefield,Philip J. Mease,Clifton O. Bingham,Michael Hughes,Doug G Altman,Marc Buyse,Sally Galbraith,George A. Wells +21 more
TL;DR: Further development and application of this schema provides incentives and guidance for effective biomarker and surrogate endpoint research, and more efficient drug discovery, development, and approval.
Journal ArticleDOI
Defining an International Standard Set of Outcome Measures for Patients with Hip or Knee Osteoarthritis: Consensus of the International Consortium for Health Outcomes Measurement Hip and Knee Osteoarthritis Working Group
Ola Rolfson,Ola Rolfson,Stephanie C. Wissig,Lisa Lisa van Maasakkers,Caleb Stowell,Ilana N. Ackerman,David C. Ayers,Thomas Barber,Thami Benzakour,Kevin J. Bozic,Nicolaas C. Budhiparama,James Caillouette,Philip G. Conaghan,Leif Dahlberg,Jennifer Dunn,John Grady-Benson,Said A. Ibrahim,Sally Lewis,Henrik Malchau,Mojieb Manzary,Lyn March,Nader Nassif,Rob G H H Nelissen,Noel Smith,Patricia D. Franklin +24 more
TL;DR: A minimum Standard Set of outcome measures and case‐mix factors for monitoring, comparing, and improving health care for patients with clinically diagnosed hip or knee osteoarthritis (OA) with a focus on defining the outcomes that matter most to patients is defined.
Journal ArticleDOI
Cognitive Impairment in Rheumatoid Arthritis: A Systematic Review
TL;DR: A systematic review of a number of studies reported high rates of cognitive impairment in adults with RA to identify and explore the rates and types of Cognitive impairment in RA.